A startup in Fukushima Prefecture develops lab instruments to reduce stress on animals during experiments. Led by founder Naoyuki Kayamoto, Hundred seeks to balance scientific advancement with animal welfare. Animal testing remains foundational to modern medicine but raises concerns over animal distress.
Animal testing, a practice widespread since the 19th century, forms the bedrock of modern medicine. It is crucial for confirming the efficacy of pharmaceuticals and vaccines, elucidating disease mechanisms, and creating new treatments and preventive measures. Globally, experiments on animals like mice and rats occur over 700 million times annually, often involving failures that cause distress to the subjects.
In response, there is an international movement toward alternative methods that prioritize animal welfare. In Japan, Naoyuki Kayamoto, 47, stands out as a key proponent. He established Hundred, a medical device startup in Koriyama, Fukushima Prefecture, in June 2016. The company produces lab instruments designed to minimize stress on animals during experiments.
Hundred's efforts emphasize the ethical dimensions of animal testing while preserving research integrity. Originating in Fukushima, this venture contributes to broader advancements in animal welfare.